Is Enhancement the Price of Prevention in Human Gene Editing?

Juengst, Eric T; Henderson, Gail E; Walker, Rebecca L; Conley, John M; MacKay, Douglas; Meagher, Karen M; Saylor, Katherine; Waltz, Margaret; Kuczynski, Kristine J; Cadigan, R Jean

Juengst, Eric T; Henderson, Gail E; Walker, Rebecca L; Conley, John M; MacKay, Douglas; Meagher, Karen M; Saylor, Katherine; Waltz, Margaret; Kuczynski, Kristine J; Cadigan, R Jean.

Afiliação

Juengst ET; 1 Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Henderson GE; 2 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Walker RL; 3 UNC Center for Bioethics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Conley JM; 1 Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
MacKay D; 1 Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Meagher KM; 4 School of Law, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Saylor K; 5 Department of Public Policy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Waltz M; 6 Department of Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.
Kuczynski KJ; 5 Department of Public Policy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Cadigan RJ; 1 Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

CRISPR J ; 1: 351-354, 2018 12.

Article em En | MEDLINE | ID: mdl-31021238

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: CRISPR J Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google